Tissue type-specific expression of the dsRNA-binding protein 76 and genome-wide elucidation of its target mRNAs.
| dc.contributor.author | Neplioueva, Valentina | |
| dc.contributor.author | Dobrikova, Elena Y | |
| dc.contributor.author | Mukherjee, Neelanjan | |
| dc.contributor.author | Keene, Jack D | |
| dc.contributor.author | Gromeier, Matthias | |
| dc.contributor.editor | Najbauer, Joseph | |
| dc.coverage.spatial | United States | |
| dc.date.accessioned | 2011-06-21T17:31:33Z | |
| dc.date.issued | 2010-07-23 | |
| dc.description.abstract | BACKGROUND: RNA-binding proteins accompany all steps in the life of mRNAs and provide dynamic gene regulatory functions for rapid adjustment to changing extra- or intracellular conditions. The association of RNA-binding proteins with their targets is regulated through changing subcellular distribution, post-translational modification or association with other proteins. METHODOLOGY: We demonstrate that the dsRNA binding protein 76 (DRBP76), synonymous with nuclear factor 90, displays inherently distinct tissue type-specific subcellular distribution in the normal human central nervous system and in malignant brain tumors of glial origin. Altered subcellular localization and isoform distribution in malignant glioma indicate that tumor-specific changes in DRBP76-related gene products and their regulatory functions may contribute to the formation and/or maintenance of these tumors. To identify endogenous mRNA targets of DRBP76, we performed RNA-immunoprecipitation and genome-wide microarray analyses in HEK293 cells, and identified specific classes of transcripts encoding critical functions in cellular metabolism. SIGNIFICANCE: Our data suggest that physiologic DRBP76 expression, isoform distribution and subcellular localization are profoundly altered upon malignant transformation. Thus, the functional role of DRBP76 in co- or post-transcriptional gene regulation may contribute to the neoplastic phenotype. | |
| dc.description.version | Version of Record | |
| dc.identifier | ||
| dc.identifier.eissn | 1932-6203 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.language.iso | en_US | |
| dc.publisher | Public Library of Science (PLoS) | |
| dc.relation.ispartof | PLoS One | |
| dc.relation.isversionof | 10.1371/journal.pone.0011710 | |
| dc.relation.journal | Plos One | |
| dc.subject | Animals | |
| dc.subject | Brain | |
| dc.subject | Cell Line | |
| dc.subject | Cell Line, Tumor | |
| dc.subject | Fluorescent Antibody Technique | |
| dc.subject | Humans | |
| dc.subject | Immunoblotting | |
| dc.subject | In Vitro Techniques | |
| dc.subject | Macaca | |
| dc.subject | Mice | |
| dc.subject | Nuclear Factor 90 Proteins | |
| dc.subject | Oligonucleotide Array Sequence Analysis | |
| dc.subject | Protein Isoforms | |
| dc.subject | RNA, Messenger | |
| dc.subject | Reverse Transcriptase Polymerase Chain Reaction | |
| dc.title | Tissue type-specific expression of the dsRNA-binding protein 76 and genome-wide elucidation of its target mRNAs. | |
| dc.title.alternative | ||
| dc.type | Journal article | |
| duke.date.pubdate | 2010-7-23 | |
| duke.description.issue | 7 | |
| duke.description.volume | 5 | |
| pubs.author-url | ||
| pubs.begin-page | e11710 | |
| pubs.issue | 7 | |
| pubs.organisational-group | Basic Science Departments | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Duke Cancer Institute | |
| pubs.organisational-group | Institutes and Centers | |
| pubs.organisational-group | Medicine | |
| pubs.organisational-group | Medicine, Infectious Diseases | |
| pubs.organisational-group | Medicine, Rheumatology and Immunology | |
| pubs.organisational-group | Molecular Genetics and Microbiology | |
| pubs.organisational-group | Neurosurgery | |
| pubs.organisational-group | School of Medicine | |
| pubs.publication-status | Published online | |
| pubs.volume | 5 |